Yahoo Finance Insider Sale: Chief Accounting Officer Victoria Baltrus Sells Shares of Oscar Health Inc (OSCR)
Victoria Baltrus, the Chief Accounting Officer of Oscar Health Inc (NYSE:OSCR), sold 7,873 shares of the company on June 4, 2024, according to a recent SEC Filing. Following this transaction, the insider now owns 127,555 shares of the company.
Oscar Health Inc is a technology-driven health insurance company that focuses on providing individual and family health insurance products. The company leverages technology, data, and design to humanize and simplify the healthcare experience, aiming to make health insurance coverage more accessible and affordable.
Over the past year, Victoria Baltrus has sold a total of 18,278 shares and has not purchased any shares. The insider transaction history for Oscar Health Inc shows a total of 26 insider sells and no insider buys over the past year.
On the day of the sale, shares of Oscar Health Inc were trading at $19.45, giving the company a market cap of approximately $4.495 billion. The stock is currently considered Significantly Overvalued with a price-to-GF Value ratio of 1.68, based on a GF Value of $11.61.
The GF Value is calculated considering historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also includes adjustments based on the companys past performance and expected future business outcomes.
This insider sale might interest investors tracking insider behaviors as an indicator of the companys future performance and valuation perspectives.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
